[1]
2021. Molnupirvir-induced SARS-CoV-2 mutagenesis mechanism and results of this antiviral in patients affected by COVID-19. Research, Society and Development. 10, 15 (Nov. 2021), e231101522916. DOI:https://doi.org/10.33448/rsd-v10i15.22916.